De novo thrombotic microangiopathy (TMA) can occur after kidney transplantation. An abnormality of the alternative pathway of complement must be suspected and searched for, even in presence of a secondary cause. We report the case of a 23-year-old female patient who was transplanted with a kidney from her mother for end-stage renal disease secondary to Hinman syndrome. Early after transplantation, she presented with 2 episodes of severe pyelonephritis, associated with acute kidney dysfunction and biological and histological features of TMA. Investigations of the alternative pathway of the complement system revealed atypical haemolytic uremic syndrome secondary to complement factor I mutation, associated with mutations in CD46 and complement...
Atypical haemolytic uraemic syndrome is a disease caused by complement regulation abnormalities that...
Background Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by systemic ...
SummaryHemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytop...
De novo thrombotic microangiopathy (TMA) can occur after kidney transplantation. An abnormality of t...
Mutations in one or more genes encoding complement-regulatory proteins predispose to atypical hemoly...
Disorders in the regulation of the alternate complement pathway often resultin complement-mediated d...
Risk for atypical hemolytic uremic syndrome (aHUS) recurrence after renal transplantation is low wit...
Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belo...
Atypical hemolytic uremic syndrome (aHUS) is a rare entity. It is characterized by a thrombotic micr...
We present a case of an unsensitized patient with end-stage kidney disease secondary to atypical hae...
The pathophysiology of atypical haemolytic-uraemic syndrome (aHUS) occurring de novo after renal tra...
Thrombotic microangiopathy (TMA) is characterized by microangiopathic hemolytic anemia, thrombocytop...
Background Atypical Hemolytic Uremic Syndrome (aHUS) is an ultra-rare disease that potentially leads...
Background: Transplantation-associated thrombotic microangiopathy (TA-TMA) is relatively rare and ma...
Introduction. Posttransplant thrombotic microangiopathy (TMA)/hemolytic uremic syndrome (HUS) can oc...
Atypical haemolytic uraemic syndrome is a disease caused by complement regulation abnormalities that...
Background Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by systemic ...
SummaryHemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytop...
De novo thrombotic microangiopathy (TMA) can occur after kidney transplantation. An abnormality of t...
Mutations in one or more genes encoding complement-regulatory proteins predispose to atypical hemoly...
Disorders in the regulation of the alternate complement pathway often resultin complement-mediated d...
Risk for atypical hemolytic uremic syndrome (aHUS) recurrence after renal transplantation is low wit...
Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belo...
Atypical hemolytic uremic syndrome (aHUS) is a rare entity. It is characterized by a thrombotic micr...
We present a case of an unsensitized patient with end-stage kidney disease secondary to atypical hae...
The pathophysiology of atypical haemolytic-uraemic syndrome (aHUS) occurring de novo after renal tra...
Thrombotic microangiopathy (TMA) is characterized by microangiopathic hemolytic anemia, thrombocytop...
Background Atypical Hemolytic Uremic Syndrome (aHUS) is an ultra-rare disease that potentially leads...
Background: Transplantation-associated thrombotic microangiopathy (TA-TMA) is relatively rare and ma...
Introduction. Posttransplant thrombotic microangiopathy (TMA)/hemolytic uremic syndrome (HUS) can oc...
Atypical haemolytic uraemic syndrome is a disease caused by complement regulation abnormalities that...
Background Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by systemic ...
SummaryHemolytic uremic syndrome (HUS) is a triad of microangiopathic hemolytic anemia, thrombocytop...